M6P Therapeutics Receives Six Rare Pediatric Disease Designations from the US FDA for ...

Retrieved on: 2021-01-28 12:45:00

Tags for this article:

Click the tags to see associated articles and topics

M6P Therapeutics Receives Six Rare Pediatric Disease Designations from the US FDA for .... View article details on hiswai:

Excerpt

M6P Therapeutics is a privately held, venture-backed biotechnology company developing the next-generation targeted recombinant enzyme and ...

Article found on: www.oaoa.com